Table 1.
Mediators measured in sputum samples
| Mediators included in analysis | Not measurable in >50 % of samples, excluded |
|---|---|
| Factor VII |
Brain-Derived Neurotrophic Factor (BDNF) |
| Fibrinogen |
C-Reactive Protein (CRP) |
| Ferritin (FRTN) |
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) |
| Intercellular Adhesion Molecule 1 (ICAM-1) |
Interferon gamma (IFN-gamma) |
| Interleukin-1 alpha (IL-1 alpha) |
Interleukin-17 (IL-17) |
| Interleukin-1 beta (IL-1 beta) |
Interleukin-2 (IL-2) |
| Interleukin-1 receptor antagonist (IL-1ra) |
Interleukin-3 (IL-3) |
| Interleukin-6 (IL-6) |
Interleukin-4 (IL-4) |
| Interleukin-8 (IL-8) |
Interleukin-5 (IL-5) |
| Interleukin-15 (IL-15) |
Interleukin-7 (IL-7) |
| Interleukin-18 (IL-18) |
Interleukin-10 (IL-10) |
| Monocyte Chemotactic Protein 1 (CCL2) |
Interleukin-12 Subunit p70 (IL-12p70) |
| Macrophage Inflammatory Protein-1 beta (CCL4) |
Interleukin-12 Subunit p40 (IL-12p40) |
| Eotaxin-1 (CCL11) |
Interleukin-23 (IL-23) |
| Matrix Metalloproteinase-3 (MMP-3) |
Macrophage Inflammatory Protein-1 alpha (CCL-3) |
| Matrix Metalloproteinase-9 (MMP-9) |
Matrix Metalloproteinase-2 (MMP-2) |
| Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) |
Stem Cell Factor (SCF) |
| Tumor Necrosis Factor alpha (TNF-alpha) |
T-Cell-Specific Protein (CCL-5) |
| Tumor Necrosis Factor Receptor 2 (TNFR2) |
Tumor Necrosis Factor β (TNF-β) |
| Vascular Cell Adhesion Molecule-1 (VCAM-1) |
von Willebrand Factor (vWF) |
| Vascular Endothelial Growth Factor (VEGF) |